PD-L1 22C3 IHC with Tumor Proportion Score (TPS) Interpretation, pembrolizumab (KEYTRUDA) and cemiplimab-rwlc (LIBTAYO) (Change effective as of 05/20/24: Refer to 3017615)
CPT Codes
88360
Testing
Search our extensive Laboratory Test Directory to find test codes, ordering recommendations, specimen stability information, Test Fact Sheets, and more.
This section highlights our specialized offerings and is separate from our Laboratory Test Directory.
Services
Education Center
About
PD-L1 22C3 IHC with Tumor Proportion Score (TPS) Interpretation, pembrolizumab (KEYTRUDA) and cemiplimab-rwlc (LIBTAYO) (Change effective as of 05/20/24: Refer to 3017615)
88360